Invitrogen Joins EPA’s Climate Leaders Program

  
    
  
  
    
      As a part of its continued commitment to environmental sustainability, 
      Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life 
      science technologies for research, production and diagnostics, today 
      announced its participation in the U.S. Environmental Protection Agency’s 
      (EPA’s) Climate Leaders program. By 
      participating in Climate Leaders, Invitrogen has pledged to reduce its 
      corporate-wide greenhouse gas emissions.
    
    
      Climate Leaders is an EPA industry-government partnership that works 
      with companies to develop comprehensive climate change strategies. 
      Partner companies commit to reducing their impact on the global 
      environment by completing a corporate-wide inventory of their greenhouse 
      gas emissions based on a quality management system, setting aggressive 
      reduction goals, and annually reporting their progress to EPA. Through 
      program participation, companies create a credible record of their 
      accomplishments and receive EPA recognition as corporate environmental 
      leaders.
    
    
      “EPA applauds our corporate partners who are 
      reducing their climate footprints in cost-effective ways,” 
      said EPA Administrator Stephen L. Johnson. “Not 
      only is Invitrogen contributing to this country’s 
      energy independence, the company is proving that businesses can save 
      green by going green.”
    
    
      Invitrogen is already demonstrating corporate climate change leadership 
      by embracing reduction of its CO2 emissions by focusing on energy 
      conservation and efficiency, alternative sources of energy, LEED 
      certification of its buildings, and technological innovation.
    
    
      “Addressing climate change is a key part of 
      Invitrogen’s corporate responsibility,” 
      said Cristina Amorim, Invitrogen’s Sr. 
      Director of Global Environmental Health and Safety. “With 
      the implementation of a number of energy conservation projects, 
      Invitrogen has already decreased our carbon dioxide emissions by 35 
      percent since 2004.”
    
    
      Invitrogen is active in other worldwide environmental sustainability 
      programs in addition to the EPA’s Climate 
      Leaders program. These include:
    
    
      
        In Carlsbad, Calif., more than 26 tons of electrical equipment waste 
        has been recycled, preventing it from filling landfills in 2007.
      
      
        In Norway, cogeneration transforms waste into energy—every 
        year, 840 tons of flammable hazardous waste is burned, generating heat 
        energy for offices.
      
      
        In Frederick, Md., Invitrogen reduced one of its hazardous waste 
        streams in the manufacturing area by 96% in 2007.
      
      
        In Inchinnan, United Kingdom, the site implemented smart processes, 
        saving 14,000 cubic meters of water per year, recycling 40 tons of 
        cardboard and paper per year and preventing 170 tons/year of bottled 
        liquid waste from being disposed in landfills.
      
    
    
      For more information about Invitrogen’s 
      corporate environmental responsibility programs, click here. 
      For more information about Climate Leaders, visit http://www.epa.gov/climateleaders.
    
    
      About Invitrogen
    
    
      Invitrogen Corporation (NASDAQ:IVGN) provides products and services that 
      support academic and government research institutions and pharmaceutical 
      and biotech companies worldwide in their efforts to improve the human 
      condition. The company provides essential life science technologies for 
      disease research, drug discovery, and commercial bioproduction. 
      Invitrogen's own research and development efforts are focused on 
      breakthrough innovation in all major areas of biological discovery 
      including functional genomics, proteomics, stem cells, cell therapy and 
      cell biology -- placing Invitrogen's products in nearly every major 
      laboratory in the world. Founded in 1987, Invitrogen is headquartered in 
      Carlsbad, California, and conducts business in more than 70 countries 
      around the world. The company employs approximately 4,700 scientists and 
      other professionals and had revenues of approximately $1.3 billion in 
      2007. For more information, visit www.invitrogen.com.